Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for advanced non-small-cell lung cancer
Vera Hirsh, Isamu Okamoto, Jeremy K. Hon, Ray D. Page, James Orsini, Hiroshi Sakai, Hui Zhang, Markus F. Renschler, Mark A. Socinski
研究成果: ジャーナルへの寄稿 › 学術誌 › 査読
22
被引用数
(Scopus)